Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-08-29 00:00:00 ET · period of report 2023-08-25 · accession 0001127602-23-023353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-29 | 2023-08-25+ | TMO | Lagarde Michel | EVP, COO | F - Tax | $542.86 | -992.14 | 18.0K | -5% | -$538.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-28 | F | D | 131.51 | $545.19 | 17,687.77 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-28 | F | D | 218.54 | $545.19 | 17,819.28 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-25 | F | D | 642.09 | $541.59 | 18,037.82 | D | — | — |